Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Dawn Caroline Goff has worked on the following 9 EPO patent applications which have been published in the last five years:

EP12838132

ANTIBACTERIAL COMPOUNDS

IPC classification:
A01N 57/00
Applicant:
Glaxo Group Limited
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP12859359

METHOD OF TREATING CANCER WITH MAGEA3 IMMUNOTHERAPEUTIC WITH BRAF INHIBITOR AND/OR MEK INHIBITOR

IPC classification:
A01N 43/40, A61K 31/54, A61K 39/00
Applicant:
GlaxoSmithKline LLC
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743888

ANTACID TABLET

IPC classification:
A61K 33/10
Applicant:
GlaxoSmithKline LLC
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13718590

NOVEL COMPOUNDS

IPC classification:
A61K 31/18, A61P 11/06, A61P 17/06, C07C 311/21, C07C 311/29, C07C 311/44, C07D 205/04, C07D 207/08, C07D 239/54, C07D 265/30, C07D 265/32, C07D 309/04, C07D 309/06, C07D 309/10, C07D 319/12
Applicant:
Glaxo Group Limited
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13835019

METHOD OF ADJUVANT CANCER TREATMENT

IPC classification:
A61K 31/506, A61K 31/519, A61P 35/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline LLC
Agent:
Sewkian Rudge, Novartis Pharma AG
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13820853

2 SUBSTITUTED CEPHEM COMPOUNDS

IPC classification:
A61K 31/546, C07D 501/50, C07D 505/24
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11831214

BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS

IPC classification:
A01N 43/52, A61K 31/4164, C07D 235/08, C07D 235/10, C07D 235/24, C07D 401/10, C07D 403/04, C07D 403/10, C07D 405/04, C07D 405/10, C07D 409/10, C07D 413/04, C07D 413/10, C07D 417/04, C07D 417/10, C07D 513/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED
EP14846138

COMBINATION DRUG THERAPY

IPC classification:
A61K 31/4166, A61K 31/535, C07D 233/86, C07D 413/10
Applicant:
GlaxoSmithKline LLC
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14809779

NOVEL MILK BEVERAGE COMPOSITION COMPRISING CREATINE

IPC classification:
A23C 9/152, A23C 9/154, A23C 11/10
Applicant:
Glaxo Group Limited
Agent:
Dawn Caroline Goff, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature